Phase 3 trials of the Turkish-developed COVID-19 vaccine Turkovac will take place in Kyrgyzstan, Vice President Fuat Oktay said.
Oktay announced the trials in Kyrgyzstan following his trip to the Central Asian republic.
“We are making an unremitting effort to offer our domestic vaccine to the service of not only our nation, but all humanity,” the vice president said.
Oktay also said that the Turkish government was in talks with several other countries over Turkovac studies.
“Negotiations continue with many countries, including Pakistan, Azerbaijan, Argentina, Colombia and Poland, on holding Phase 3 trials,” he said.
Oktay noted that important steps have been taken for Turkovac to become a vaccine used all over the world and gain international recognition.
Turkovac’s Phase 3 trials kicked off in Turkey in late June, and this week Health Minister Fahrettin Koca said the Turkish vaccine was nearly ready to apply for emergency use approval.